Stay updated with breaking news from Clene inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reaffirmed their buy rating on shares of Clene (NASDAQ:CLNN – Free Report) in a report issued on Tuesday, Benzinga reports. The brokerage currently has a $7.00 price target on the stock. Separately, Benchmark reissued a buy rating and set a $5.00 target price on shares of Clene in a research note on Thursday, […] ....
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Benchmark restated their buy rating on shares of Clene (NASDAQ:CLNN – Free Report) in a report issued on Thursday morning, Benzinga reports. Benchmark currently has a $5.00 target price on the stock. Separately, HC Wainwright reissued a buy rating and set a $7.00 price objective on shares of Clene in a research note on Wednesday, […] ....
Benchmark reissued their buy rating on shares of Clene (NASDAQ:CLNN – Free Report) in a report issued on Thursday morning, Benzinga reports. Benchmark currently has a $5.00 price objective on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $7.00 price target on shares of Clene in a research note on Wednesday, […] ....